SWAB MARKET ANALYSIS

Swab plays a major role in advance healthcare, as they are part of surgery and medicine. It is widely used in first aid kit, wound cleansing, and at injection sites. Swab are made of absorbent material, sometimes pertained with alcohol, iodine, cetrimide or cholrhexidine, which imparts medical properties to it.

The global swab market size was valued at US$ 578.6 million in 2017, and is expected to exhibit a CAGR of 6.6% over the forecast period (2018 – 2026).

Figure 1. Global Swab Market Value (US$ Mn), by Region, 2017

To learn more about this report, request a free sample copy

                                                                           Source: Coherent Market Insights Analysis

Increasing incidence of surgeries is expected to propel growth of the swab market

Swab is used in for cleaning wounds and disinfecting the pre injection site. High prevalence of chronic diseases is expected to propel demand for surgical procedures, which in turn is expected to drive the market growth. According to the, American College of Cardiology Journal (JACC) in December 2012, an estimated 40% people above aged 25 years are diagnosed with high blood pressure in the U.S., and the number of patients with elevated blood pressure has increased from 600 million in 1980 to a billion in 2008.

Moreover, increasing incidences of road accidents and falls associated wound and injuries are propelling growth of the swab market over the forecast period. According to the World Health Organization (WHO) factsheet 2018, road accidents caused around 20 and 50 million injuries annually around the world. Road traffic injuries are the leading cause of death among people aged between 5 and 29 years, and more than 1.35 million people die annually, as a result of road traffic crashes globally.      

Figure 2. Global Swab Market Share (%), by Shaft Type, 2018 and 2026

To learn more about this report, request a free sample copy

                                                                      Source: Coherent Market Insights Analysis

Increasing prevalence of cardiovascular diseases in North America is expected to bolster the market growth

North America holds dominant position in the global swab market, owing to high prevalence of cardiovascular disease, which leads to angioplasty and other surgeries. According to the American Heart Association, 2016, cardiovascular diseases accounted for around 17.3 million deaths annually worldwide, whereas an estimated 23.3 million people are expected to die from cardiovascular disease by 2030.

Moreover, increasing geriatric population susceptible to cardiovascular disease in this region is expected to bolster the market growth over the forecast period. According to the American Heart Association, December 2015, an estimated 85.6 million Americans suffers from some form of cardiovascular disease and nearly 50% of African and America adults are diagnosed with cardiovascular disease in which women comprised around 48% and men around 46%

 Moreover, key players in the market are focused on receiving the U.S. Food and Drug Administration (FDA) approval for novel products in diagnostic tools. For instance, in April 2018, Parsagen Diagnostic Inc., received the U.S. Food and Drug Administration (FDA) approval for PartoSure test, which consist of sterile flocked swab, lateral flow test strip, and vial with extraction solvent.

Key Players

Major players operating in the global swab market include Puritan Medical Products, Copan Diagnostics, Inc., Sarstedt AG & Co. KG, FI Medical MWE, Cleancross Co.,LTD., AdvaCare Systems, GPC Medical Ltd., Elmex Controls Pvt Ltd., and Citotest Labware Manufacturing Co., Ltd.